Stephen M Gorga1, Rashmi D Sahay2, David J Askenazi3, Brian C Bridges4, David S Cooper5, Matthew L Paden6, Michael Zappitelli7, Katja M Gist8, Jason Gien8, Rajit K Basu6, Jennifer G Jetton9, Heidi J Murphy10, Eileen King3,11, Geoffrey M Fleming4, David T Selewski12. 1. Department of Pediatrics, University of Michigan Medical School, Ann Arbor, MI, USA. 2. Division of Biostatistics and Epidemiology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA. 3. Department of Pediatrics, University of Alabama Birmingham, Birmingham, Alabama, USA. 4. Department of Pediatrics, Vanderbilt University School of Medicine, Nashville, TN, USA. 5. Department of Pediatrics, The Heart Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA. 6. Children's Healthcare of Atlanta, Emory University School of Medicine, Atlanta, GA, USA. 7. Department of Pediatrics, Toronto Hospital for Sick Children, Toronto, Canada and McGill University Health Centre, Montreal, Canada. 8. Department of Pediatrics, Children's Hospital of Colorado University of Colorado Anschutz Medical Campus Aurora, Aurora, CO, USA. 9. Division of Nephrology, Dialysis and Transplantation, Stead Family Department of Pediatrics, University of Iowa Children's Hospital, Iowa City, IA, USA. 10. Department of Pediatric, Medical University of South Carolina, Charleston, SC, USA. 11. Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH, USA. 12. Department of Pediatric, Medical University of South Carolina, Charleston, SC, USA. selewski@musc.edu.
Abstract
OBJECTIVE: The aim of this study was to characterize continuous renal replacement therapy (CRRT) utilization on extracorporeal membrane oxygenation (ECMO) and to determine the association of both fluid overload (FO) at CRRT initiation and fluid removal during CRRT with mortality in a large multicenter cohort. METHODS: Retrospective chart review of all children < 18 years of age concurrently treated with ECMO and CRRT from January 1, 2007, to December 31, 2011, at six tertiary care children's hospital. Children treated with hemodialysis or peritoneal dialysis were excluded from the FO analysis. MEASUREMENTS AND MAIN RESULTS: A total of 756 of the 1009 children supported with ECMO during the study period had complete FO data. Of these, 357 (47.2%) received either CRRT or were treated with an in-line filter and thus entered into the final analysis. Survival to ECMO decannulation was 66.4% and survival to hospital discharge was 44.3%. CRRT initiation occurred at median of 1 day (IQR 0, 2) after ECMO initiation. Median FO at CRRT initiation was 20.1% (IQR 5, 40) and was significantly lower in ECMO survivors vs. non-survivors (15.3% vs. 30.5% p = 0.005) and in hospital survivors vs. non-survivors (13.5% vs. 25.9%, p = 0.004). Median FO at CRRT discontinuation was significantly lower in ECMO survivors (23% vs. 37.6% p = 0.002) and hospital survivors vs. non-survivors (22.6% vs. 36.1%, p = 0.002). In ECMO survivors, after adjusting for pH at CRRT initiation, non-renal complications, ECMO mode, support type, center, patient age and AKI, FO at CRRT initiation (p = 0.01), and FO at CRRT discontinuation (p = 0.0002) were independently associated with duration of ECMO. In a similar multivariable analysis, FO at CRRT initiation (adjusted adds ratio [aOR] 1.09, 95% CI 1.00-1.18, p = 0.045) and at CRRT discontinuation (aOR 1.11, 95% CI 1.03-1.19, p = 0.01) were independently associated with hospital mortality. CONCLUSIONS: In a multicenter pediatric ECMO cohort, this study demonstrates that severe FO was very common at CRRT initiation. We found an independent association between the degree of FO at CRRT initiation with adverse outcomes including mortality and increased duration of ECMO support. The results suggest that intervening prior to the development of significant FO may be a clinical therapeutic target and warrants further evaluation.
OBJECTIVE: The aim of this study was to characterize continuous renal replacement therapy (CRRT) utilization on extracorporeal membrane oxygenation (ECMO) and to determine the association of both fluid overload (FO) at CRRT initiation and fluid removal during CRRT with mortality in a large multicenter cohort. METHODS: Retrospective chart review of all children < 18 years of age concurrently treated with ECMO and CRRT from January 1, 2007, to December 31, 2011, at six tertiary care children's hospital. Children treated with hemodialysis or peritoneal dialysis were excluded from the FO analysis. MEASUREMENTS AND MAIN RESULTS: A total of 756 of the 1009 children supported with ECMO during the study period had complete FO data. Of these, 357 (47.2%) received either CRRT or were treated with an in-line filter and thus entered into the final analysis. Survival to ECMO decannulation was 66.4% and survival to hospital discharge was 44.3%. CRRT initiation occurred at median of 1 day (IQR 0, 2) after ECMO initiation. Median FO at CRRT initiation was 20.1% (IQR 5, 40) and was significantly lower in ECMO survivors vs. non-survivors (15.3% vs. 30.5% p = 0.005) and in hospital survivors vs. non-survivors (13.5% vs. 25.9%, p = 0.004). Median FO at CRRT discontinuation was significantly lower in ECMO survivors (23% vs. 37.6% p = 0.002) and hospital survivors vs. non-survivors (22.6% vs. 36.1%, p = 0.002). In ECMO survivors, after adjusting for pH at CRRT initiation, non-renal complications, ECMO mode, support type, center, patient age and AKI, FO at CRRT initiation (p = 0.01), and FO at CRRT discontinuation (p = 0.0002) were independently associated with duration of ECMO. In a similar multivariable analysis, FO at CRRT initiation (adjusted adds ratio [aOR] 1.09, 95% CI 1.00-1.18, p = 0.045) and at CRRT discontinuation (aOR 1.11, 95% CI 1.03-1.19, p = 0.01) were independently associated with hospital mortality. CONCLUSIONS: In a multicenter pediatric ECMO cohort, this study demonstrates that severe FO was very common at CRRT initiation. We found an independent association between the degree of FO at CRRT initiation with adverse outcomes including mortality and increased duration of ECMO support. The results suggest that intervening prior to the development of significant FO may be a clinical therapeutic target and warrants further evaluation.
Authors: David T Selewski; Timothy T Cornell; Rebecca M Lombel; Neal B Blatt; Yong Y Han; Theresa Mottes; Mallika Kommareddi; David B Kershaw; Thomas P Shanley; Michael Heung Journal: Intensive Care Med Date: 2011-04-30 Impact factor: 17.440
Authors: Geoffrey M Fleming; Rashmi Sahay; Michael Zappitelli; Eileen King; David J Askenazi; Brian C Bridges; Matthew L Paden; David T Selewski; David S Cooper Journal: Pediatr Crit Care Med Date: 2016-12 Impact factor: 3.624
Authors: Nancy G Hoover; Michael Heard; Christopher Reid; Scott Wagoner; Kristine Rogers; Jason Foland; Matthew L Paden; James D Fortenberry Journal: Intensive Care Med Date: 2008-07-15 Impact factor: 17.440
Authors: Nikoleta S Kolovos; Susan L Bratton; Frank W Moler; Edward L Bove; Richard G Ohye; Robert H Bartlett; Thomas J Kulik Journal: Ann Thorac Surg Date: 2003-11 Impact factor: 4.330
Authors: Matthieu Schmidt; Michael Bailey; Joshua Kelly; Carol Hodgson; D James Cooper; Carlos Scheinkestel; Vincent Pellegrino; Rinaldo Bellomo; David Pilcher Journal: Intensive Care Med Date: 2014-06-17 Impact factor: 17.440
Authors: Kevin A Pettit; David T Selewski; David J Askenazi; Rajit K Basu; Brian C Bridges; David S Cooper; Geoffrey M Fleming; Jason Gien; Stephen M Gorga; Jennifer G Jetton; Eileen C King; Heidi J Steflik; Matthew L Paden; Rashmi D Sahay; Michael Zappitelli; Katja M Gist Journal: Pediatr Nephrol Date: 2022-08-09 Impact factor: 3.651
Authors: Matteo Di Nardo; Ali H Ahmad; Pietro Merli; Matthew S Zinter; Leslie E Lehman; Courtney M Rowan; Marie E Steiner; Sangeeta Hingorani; Joseph R Angelo; Hisham Abdel-Azim; Sajad J Khazal; Basirat Shoberu; Jennifer McArthur; Rajinder Bajwa; Saad Ghafoor; Samir H Shah; Hitesh Sandhu; Karen Moody; Brandon D Brown; Maria E Mireles; Diana Steppan; Taylor Olson; Lakshmi Raman; Brian Bridges; Christine N Duncan; Sung Won Choi; Rita Swinford; Matt Paden; James D Fortenberry; Giles Peek; Pierre Tissieres; Daniele De Luca; Franco Locatelli; Selim Corbacioglu; Martin Kneyber; Alessio Franceschini; Simon Nadel; Matthias Kumpf; Alessandra Loreti; Roelie Wösten-Van Asperen; Orsola Gawronski; Joe Brierley; Graeme MacLaren; Kris M Mahadeo Journal: Lancet Child Adolesc Health Date: 2021-12-09
Authors: David T Selewski; David J Askenazi; Kianoush Kashani; Rajit K Basu; Katja M Gist; Matthew W Harer; Jennifer G Jetton; Scott M Sutherland; Michael Zappitelli; Claudio Ronco; Stuart L Goldstein; Theresa Ann Mottes Journal: Pediatr Nephrol Date: 2021-01-12 Impact factor: 3.714